Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kristina A M Arendt

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Current Opinion in Pulmonary Medicine|April 14, 2017
Lung carcinogenesis and fibrosis taken together: just coincidence?Ioanna Giopanou, Kristina A M Arendt, Georgios T Stathopoulos
Molecular & Cellular Oncology|October 24, 2017
RAS oncogenes direct metastasisMagda Spella, Antonia Marazioti, Kristina A M Arendt, et al.
British Journal of Cancer|May 3, 2025
SMAD2 linker phosphorylation impacts overall survival, proliferation, TGFβ1-dependent gene expression and pluripotency-related proteins in NSCLCDörte Nitschkowski, Tim Vierbuchen, Holger Heine, et al.
Biomedicines|March 25, 2022
An In Vivo Inflammatory Loop Potentiates KRAS BlockadeKristina A M Arendt, Giannoula Ntaliarda, Vasileios Armenis, et al.
Carcinogenesis|March 5, 2019
Tobacco chemical-induced mouse lung adenocarcinoma cell lines pin the prolactin orthologue proliferin as a lung tumour promoterNikolaos I Kanellakis, Anastasios D Giannou, Mario A A Pepe, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 19, 2017
Cancer cells induce interleukin-22 production from memory CD4<sup>+</sup> T cells via interleukin-1 to promote tumor growthCornelia Voigt, Peter May, Adrian Gottschlich, et al.
Cancer Medicine|February 27, 2019
Comprehensive clinical profiling of the Gauting locoregional lung adenocarcinoma donorsLaura V Klotz, Yves Courty, Michael Lindner, et al.
Cancers|March 29, 2023
Non-Oncogene Addiction of <i>KRAS</i>-Mutant Cancers to IL-1β via Versican and Mononuclear IKKβMagda Spella, Giannoula Ntaliarda, Georgios Skiadas, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Current Opinion in Pulmonary Medicine|April 14, 2017
Lung carcinogenesis and fibrosis taken together: just coincidence?Ioanna Giopanou, Kristina A M Arendt, Georgios T Stathopoulos
Molecular & Cellular Oncology|October 24, 2017
RAS oncogenes direct metastasisMagda Spella, Antonia Marazioti, Kristina A M Arendt, et al.
British Journal of Cancer|May 3, 2025
SMAD2 linker phosphorylation impacts overall survival, proliferation, TGFβ1-dependent gene expression and pluripotency-related proteins in NSCLCDörte Nitschkowski, Tim Vierbuchen, Holger Heine, et al.
Biomedicines|March 25, 2022
An In Vivo Inflammatory Loop Potentiates KRAS BlockadeKristina A M Arendt, Giannoula Ntaliarda, Vasileios Armenis, et al.
Carcinogenesis|March 5, 2019
Tobacco chemical-induced mouse lung adenocarcinoma cell lines pin the prolactin orthologue proliferin as a lung tumour promoterNikolaos I Kanellakis, Anastasios D Giannou, Mario A A Pepe, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 19, 2017
Cancer cells induce interleukin-22 production from memory CD4<sup>+</sup> T cells via interleukin-1 to promote tumor growthCornelia Voigt, Peter May, Adrian Gottschlich, et al.
Cancer Medicine|February 27, 2019
Comprehensive clinical profiling of the Gauting locoregional lung adenocarcinoma donorsLaura V Klotz, Yves Courty, Michael Lindner, et al.
Cancers|March 29, 2023
Non-Oncogene Addiction of <i>KRAS</i>-Mutant Cancers to IL-1β via Versican and Mononuclear IKKβMagda Spella, Giannoula Ntaliarda, Georgios Skiadas, et al.
Pageof 1